期刊文献+

冬凌草甲素对MG-63转移的抑制效应和分子机制研究 被引量:1

Metastasis-inhibiting Effect of Oridonin on MG-63 Cells and Its Mechanisms
下载PDF
导出
摘要 目的确定冬凌草甲素是否具有抑制MG-63细胞转移的效应及其分子机制。方法用不同浓度的冬凌草甲素作用于MG-63细胞,用体外驱化运动试验检测MG-63细胞运动驱化能力的变化;用RT-PCR检测MG-63细胞中血管内皮生长因子(VEGF)和基质金属蛋白酶(MMP-9)mRNA表达的变化;用ELISA方法检测MG-63细胞上清VEGF和MMP-9浓度的变化。结果 (1)体外驱化运动试验证明冬凌草甲素能以浓度依赖性方式抑制MG-63细胞转移;(2)冬凌草甲素以浓度依赖性方式抑制MG-63细胞及其上清中VEGF和MMP-9的表达。结论冬凌草甲素具有抑制MG-63细胞转移的能力,其机制可能与药物下调VEGF和MMP-9有关。 Objective To determine metastasis-inhibiting effect of oridonin on MG-63 cells and to explore its mechanisms. Methods After MG-63 cells were incubated with different concentrations of oridonin, the metastasis ability was analyzed with experiment of chemotaxic migration, the mRNA expressions of VEGF and MMP-9 in MG- 63 cells were analyzed by RT-PCR and the changes of concentrations of VEGF and MMP-9 in supernatant were analyzed by ELISA. Results Oridonin effectively inhibited the metastasis of MG-63 cells in a concentration-time dependent way. Oridonin effectively inhibited the expressions of VEGF and MMP-9 in MG-63 cells and supernatantin a concentration-time dependent way. Conclusion Oridonin can inhibit the metastasis of MG-63 cells effectively in a concentration-dependent manner and the molecular mechanism may relate to oridonin down-regulating VEGF and MMP-9 expressions.
出处 《食品与药品》 CAS 2013年第1期22-25,共4页 Food and Drug
关键词 冬凌草甲素 人骨肉瘤细胞株MG-63细胞 转移 分子机制 oridonin MG-63 cells metastasis molecular mechanism
  • 相关文献

参考文献10

  • 1Picci P,Ferrari S,Bacci G. Treatment recommendation for osteosarcoma and adult soft tissue sarcoma[J].Drugs,1994.82-92.
  • 2Staddon A P,Lackman R,Robinson K. Osteogenic sarcoma presenting with lung metastasis[J].Oncologist(The),2002,(02):144-153.
  • 3Thompson R C Jr,Cheng E Y,Clohisy D R. Results of treatment for metastatic osteosarcoma with neoadjuvant chemotherapy and surgery[J].Clinical Orthopaedics,2002.240-247.
  • 4韩锐;孙燕.新世纪癌的化学预防与药物治疗[M]北京:人民军医出版社,2005307-319.
  • 5Anitha J,George T. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis[J].Pathology Oncology Research,2004,(01):14-23.
  • 6Stanley Z,Cao J,Chen W T. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment[J].Oncogene,2000,(56):6642-6650.
  • 7Kakeji Y,MaeharaY,Sumiyoshi Y. Angiogenesis as a target for gastric cancer[J].Surgery,2002,(1 Suppl):S48-S54.
  • 8Tosetti F,Ferrari N,De Flora S. Angioprevention:angiogenesis is a common and key target for cancer chemopreventive agents[J].Federation of America Societies for Experimental Biology Journal,2002,(01):2-14.
  • 9Meade-Tollin L C,Wijeratne E M,Cooper D. Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens,a constituent of the herbal supplement PCSPES[J].Journal of Natural Products,2004,(01):2-4.
  • 10Ren K K,Wang H Z,Xie L P. The effects of oridonin on cell growth,cell cycle,cell migration and differentiation in melanoma cells[J].Journal of Ethnopharmacology,2006,(02):176-180.doi:10.1016/j.jep.2005.07.020.

同被引文献7

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部